IP Library Granted Patent US 8,342,331
Granted Patent B2
US 8,342,331 · App. 13/103,247 · Granted Jan 1, 2013

Sealable secondary packaging for pharmaceutical product blister pack

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,342,331
App. No.
13/103,247
Granted
Jan 1, 2013
Kind
B2
Abstract

A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).

Claims (39)

1. A pharmaceutical product supply, comprising:

a container;

a pharmaceutical product receiver, wherein said pharmaceutical product receiver comprises a plurality of receptacles, wherein each said receptacle comprises an opening;

pharmaceutical product within at least one of said plurality of receptacles of said pharmaceutical product receiver;

each receptacle of said plurality of receptacles that includes said pharmaceutical product having a corresponding covering over its corresponding said opening, wherein each said corresponding covering encloses said pharmaceutical product in its corresponding said receptacle;

adhesive on at least one of said container and said pharmaceutical product receiver; and

a release liner on said adhesive, wherein said container is disposed in a first configuration where said corresponding covering for at least one of said plurality of receptacles is accessible, wherein said container is thereafter disposable in a second configuration where no said corresponding covering for any of said plurality of receptacles is accessible through any openable access incorporated by said container, wherein said release liner is removed to expose said adhesive and for disposing and retaining said container in said second configuration, and wherein when said container is disposed in said second configuration, at least one of said plurality of receptacles still has its said corresponding covering disposed over its corresponding said opening.

2. The pharmaceutical product supply of claim 1 , wherein said container comprises a first panel, a second panel, and a third panel, wherein said second panel is between said first and third panels, wherein said pharmaceutical product receiver is incorporated by a first surface of said second panel, wherein said first panel comprises a first said adhesive and a first said release liner, wherein said third panel comprises a second said adhesive and a second said release liner, wherein said first panel is adhereable to said pharmaceutical product receiver when said first said release liner is removed and when said first panel is positioned against said first surface of said second panel, wherein said third panel is adhereable to a second surface of said second panel that is opposite of said first surface when said second said release liner is removed and when said third panel is positioned against said second surface of said second panel, and wherein each of said first and third panels lack any openable access.

3. The pharmaceutical product supply of claim 1 , wherein said container comprises a first panel, a second panel, and a third panel, wherein said second panel is said pharmaceutical product receiver, wherein said first panel comprises a first said adhesive and a first said release liner, wherein said third panel comprises a second said adhesive and a second said release liner, wherein said first panel is adhereable to a first side of said pharmaceutical product receiver when said first said release liner is removed and when said first panel is positioned against said first side of said pharmaceutical product receiver, wherein said third panel is adhereable to a second side of said pharmaceutical product receiver when said second said release liner is removed and when said third panel is positioned against said second side of said pharmaceutical product receiver, wherein said first and second sides of said pharmaceutical product receiver are oppositely disposed, and wherein each of said first and third panels lack any openable access.

4. The pharmaceutical product supply of claim 3 , wherein pharmaceutical product information is hidden from view by said pharmaceutical product receiver being sandwiched between said first and third panels and with said first and third panels being disposed in a fixed position relative to said pharmaceutical product receiver by said first and second said adhesive.

5. The pharmaceutical product supply of claim 3 , wherein labeling is hidden from view by said pharmaceutical product receiver being sandwiched between said first and third panels and with said first and third panels being disposed in a fixed position relative to said pharmaceutical product receiver by said first and second said adhesive.

6. The pharmaceutical product supply of claim 1 , wherein said container comprises first and second panels, wherein said first panel lacks any openable access, and wherein a first surface of said second panel incorporates said pharmaceutical product receiver.

7. The pharmaceutical product supply of claim 1 , wherein said container comprises first and second panels, wherein said first panel lacks any openable access, and wherein a first side of said second panel comprises a panel opening to an internal storage area in which said pharmaceutical product receiver is disposed.

8. The pharmaceutical product supply of claim 7 , wherein said adhesive and said release liner is incorporated by at least one of said first and second panels.

9. The pharmaceutical product supply of claim 1 , wherein said container comprises first and second panels, wherein said pharmaceutical product receiver is incorporated on a first side of said second panel, wherein said first panel comprises said adhesive, wherein said release liner is attached to said first panel at a location that is spaced from an intersection between said first and second panels, wherein said release liner comprises said adhesive, wherein said first panel is adhereable to at least said first side of said second panel when said release liner is pulled away from said first panel and when said first panel is positioned against said first side of said second panel, wherein said release liner is adhereable to at least a second side of said second panel when said release liner is pulled away from said first panel and when said release liner is positioned against said second side of said second panel, and wherein said first and second sides of said second panel are oppositely disposed.

10. The pharmaceutical product supply of claim 1 , wherein said container comprises first and second panels, wherein said first panel comprises said adhesive, wherein said release liner is attached to said first panel at a location that is spaced from an intersection between said first and second panels, wherein said release liner comprises said adhesive, wherein a first side of said second panel comprises a panel opening to an internal storage area in which said pharmaceutical product receiver is disposed, wherein said first panel is adhereable to at least said first side of said second panel when said release liner is pulled away from said first panel and when said first panel is positioned against said first side of said second panel, wherein said release liner is adhereable to at least a second side of said second panel when said release liner is pulled away from said first panel and when said release liner is positioned against said second side of said second panel, and wherein said first and second sides of said second panel are oppositely disposed.

11. The pharmaceutical product supply of claim 10 , further comprising a plurality of said pharmaceutical product receivers within said internal storage area.

12. The pharmaceutical product supply of claim 10 , wherein a first end of said first panel is at said intersection between said first and second panels, and wherein said release liner is attached to a second end of said first panel that is opposite of said first end.

13. The pharmaceutical product supply of claim 10 , wherein at least one of said first panel and said release liner is also adhered to an end section of said second panel when said release liner is pulled away from said first panel and when said at least one of said first panel and said release liner is positioned against said end section of said second panel.

14. The pharmaceutical product supply of claim 1 , wherein said container comprises an internal storage area, a container opening that accesses said internal storage area, and a cover to selectively block said container opening, and wherein said cover comprises said adhesive and said release liner.

15. The pharmaceutical product supply of claim 1 , wherein said container comprises first and second panels that are disposed in spaced relation, an internal storage area between said first and second panels, and a container opening that accesses said internal storage area, and wherein an inner surface of at least one of said first and second panels comprises said adhesive and said release liner.

16. The pharmaceutical product supply of claim 15 , wherein a free end of said release liner is disposed proximate said container opening.

17. The pharmaceutical product supply of claim 16 , wherein said free end of said release liner extends beyond said container opening so as to be disposed outside of said internal storage area.

18. The pharmaceutical product supply of claim 15 , wherein said container comprises a closed container end opposite of said container opening, wherein said release liner comprises first and second release liner ends, wherein said first release liner end is located closer to said closed container end than said second release liner end, wherein said release liner extends from said first release liner end toward said closed container end on said adhesive to a first location where said release liner doubles back at least toward said container opening and terminates at said second release liner end.

19. The pharmaceutical product supply of claim 18 , wherein said second release liner end extends beyond said container opening such that it is out of said internal storage area.

20. The pharmaceutical product supply of claim 1 , wherein said container comprises first and second panels, wherein said first panel comprises first and second panel sections, wherein said pharmaceutical product receiver is incorporated on a first side of said second panel, wherein said second panel section is attached to said first panel section at a location that is spaced from an intersection between said first panel section and said second panel, wherein surfaces of said first and second panel sections that face each other each comprise said adhesive, wherein at least one said release liner is provided between said surfaces of said first and second panel sections that comprise said adhesive, wherein said first panel section is adhereable to at least said first side of said second panel when said at least one said release liner is removed from between said first and second panel sections and when said first panel section is positioned against said first side of said second panel, wherein said second panel section is adhereable to at least a second side of said second panel when said at least one said release liner is removed from between said first and second panel sections and when said second panel section is positioned against said second side of said second panel, and wherein said first and second sides of said second panel are oppositely disposed.

21. The pharmaceutical product supply of claim 1 , wherein said container comprises first and second panels, wherein said first panel comprises first and second panel sections, wherein said pharmaceutical product receiver is incorporated on a first side of said second panel, wherein said second panel section is attached to said first panel section at a location that is spaced from an intersection between said first panel section and said second panel, wherein surfaces of said first and second panel sections that face each other each comprise said adhesive, wherein at least one said release liner is provided between said surfaces of said first and second panel sections that comprise said adhesive, wherein a first side of said second panel comprises a panel opening to an internal storage area in which said pharmaceutical product receiver is disposed, wherein said first panel section is adhereable to at least said first side of said second panel when said at least one said release liner is removed from between said first and second panel sections and when said first panel section is positioned against said first side of said second panel, wherein said second panel section is adhereable to at least a second side of said second panel when said at least one said release liner is removed from between said first and second panel sections and when said second panel section is positioned against said second side of said second panel, and wherein said first and second sides of said second panel are oppositely disposed.

22. The pharmaceutical product supply of claim 21 , further comprising a plurality of said pharmaceutical product receivers within said internal storage area.

23. The pharmaceutical product supply of claim 21 , wherein a first end of said first panel section is at said intersection between said first and second panels, and wherein said second panel section is attached to a second end of said first panel section that is opposite of said first end.

24. The pharmaceutical product supply of claim 21 , wherein at least one of said first and second panel sections is also adhered to an end section of said second panel.

25. A pharmaceutical product supply, comprising:

a first panel, a second panel, and a third panel, wherein said second panel is located between said first and third panels, wherein each of said first and third panels lack any openable access, wherein a first boundary region exists between said first and second panels, wherein a second boundary region exists between said second and third panels, wherein said first panel comprises a free end opposite from said first boundary region, and wherein said third panel comprises a free end opposite from said second boundary region;

a pharmaceutical product receiver associated with said second panel and comprising a plurality of receptacles, wherein each said receptacle comprises an opening;

pharmaceutical product within at least one of said plurality of receptacles of said pharmaceutical product receiver; and

each receptacle of said plurality of receptacles that includes said pharmaceutical product having a corresponding covering over its corresponding said opening, wherein each said corresponding covering encloses said pharmaceutical product in its corresponding said receptacle, wherein said first panel comprises a first adhesive and a first release liner, wherein said third panel comprises a second adhesive and a second release liner, wherein said first panel is adhereable to a first side of said second panel when said first release liner is removed and when said first panel is positioned against said first side of said second panel, and wherein said third panel is adhereable to a second side of said second panel when said second release liner is removed and when said third panel is positioned against said second side of said second panel, wherein said first and second sides of said second panel are oppositely disposed.

26. The pharmaceutical product supply of claim 25 , wherein pharmaceutical product information is hidden from view by said pharmaceutical product receiver being sandwiched between said first and third panels and with said first and third panels being disposed in a fixed position relative to said pharmaceutical product receiver by said first and second adhesives.

27. The pharmaceutical product supply of claim 25 , wherein labeling is hidden from view by said pharmaceutical product receiver being sandwiched between said first and third panels and with said first and third panels being disposed in a fixed position relative to said pharmaceutical product receiver by said first and second said adhesive.

28. The pharmaceutical product supply of claim 25 , wherein said first panel comprises first and second oppositely disposed surfaces with said first adhesive being incorporated by said first surface of said first panel, wherein said second panel comprises first and second oppositely disposed surfaces with said opening of each of said plurality of receptacles being associated with said first surface of said second panel, wherein said third panel comprises first and second oppositely disposed surfaces with said second adhesive being incorporated by said first surface of said third panel, wherein prior to removing said first and second release liners, said first release liner on said first surface of said first panel is disposed against said second surface of said second panel by moving said free end of said first panel about said first boundary region and said second surface of said third panel is disposed against said second surface of said first panel by moving said free end of said third panel about said second boundary region such that said first surface of said second panel is exposed to allow access to said corresponding covering for each of said plurality of receptacles that includes pharmaceutical product.

29. The pharmaceutical product supply of claim 28 , wherein after removing said first and second release liners, said first surface of said first panel is disposed against and bonded to said second surface of said second panel by moving said free end of said first panel about said first boundary region and said first surface of said third panel is disposed against and bonded to said first surface of said second panel by moving said free end of said third panel about said second boundary region such that said second panel is retained between said first panel and said third panel.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 31, 2025
From: SPECGX LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 072313/0063 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2017
From: MALLINCKRODT LLC
To: SPECGX LLC
Reel/Frame 044891/0376 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →